Genpact Limited
Health
Performance
7.0
Risk
Sell
Buy
Curious about the Scores? Learn more.

Genpact Limited stock rating and score history

All changes in ratings, performance and outlook tracked over time.

16.07.2026
Stability slipping. Financial grip’s not as firm as it was.
18.06.2026
Almost falling apart. Core metrics remain shaky and unstable.
09.04.2026
Trouble brewing. Volatility and pressure rising.
17.01.2026
Momentum tanked. Clearly underperforming.
G
Genpact Limited
30.18
-1.50%
7.0
Sell
Buy
Genpact Limited

Genpact Limited stock price, chart patterns and momentum

Recent price movements, trend behaviour and momentum signals based on real-time market data.

What does Genpact Limited do? Business model and key facts

Get the full picture of Genpact Limited: what it builds, where it operates, and how it makes money.

Genpact Limited Profile

Sector: Technology

Industry: Information Technology Services

Employees (FY): 145000

Genpact Limited (G) is a global professional services firm specializing in business process management and information technology solutions. The company extends its offerings across diverse geographies, including India, the wider Asian market, North and Latin America, and Europe. Its operations are structured around three primary industry segments: Banking, Capital Markets, and Insurance; Consumer Goods, Retail, Life Sciences, and Healthcare; and High Technology, Manufacturing, and Services. Genpact provides a range of strategic advisory services, such as financial counsel for Chief Financial Officers and extensive environmental, social, and governance (ESG) support. These ESG services cover critical areas like data management, carbon footprint accounting, human rights assessments, sustainability due diligence, and comprehensive ESG reporting. Its financial and accounting (F&A) service portfolio is robust, encompassing: Accounts Payable: From efficient document handling and invoice processing to approval and resolution management, and travel and expense administration. Invoice-to-Cash: Managing customer master data, credit and contract oversight, order fulfillment, billing, collections, and dispute resolution. Record-to-Report: Core accounting functions, treasury operations, tax compliance, product cost analysis, and crucial closing and reporting activities. Financial Planning and Analysis: Delivering budgeting, forecasting, and business performance reporting. Enterprise Risk and Compliance: Addressing operational risks and establishing control frameworks. Additionally, Genpact offers expert supply chain consulting and after-sales support. Its sourcing and procurement services are comprehensive, including strategic direct and indirect sourcing, category management, spend analytics, procurement operations, and master data management. The company also supports sales and commercial functions through campaign and order management, dispute resolution, lead generation, pricing optimization, and promotion strategies. In the realm of information technology, Genpact delivers end-user computing support, infrastructure management, application production support, and database management. It further drives organizational change through its transformation services, which integrate digital solutions, specialized consulting, and advanced analytics capabilities. Founded in 1997, Genpact Limited is headquartered in Hamilton, Bermuda.

shop
Company facts
Balkrishan Kalra
CEO
145000
Employees worldwide
shop
Performance
-32.78%
Last 12 months
-38.07%
Last 5 years
shop
Growth
$5.08B
Revenue year
$552.49M
Net income
shop
Valuation
$5.24B
Market Cap
14.71
Price/Earnings Ratio

Stocks related to Genpact Limited

Selected based on industry alignment and relative market positioning.

PSN
Parsons Corporation
55.18
-0.54%
5.3
Sell
Buy
Parsons Corporation
GDS
GDS Holdings Limited
32.78
+1.71%
7.4
Sell
Buy
GDS Holdings Limited
INGM
Ingram Micro Holding Corporation
29.45
+3.33%
4.9
Sell
Buy
Ingram Micro Holding Corporation
SAIC
Science Applications International Corporation
111.82
-0.75%
5.2
Sell
Buy
Science Applications International Corporation
DLB
Dolby Laboratories, Inc.
49.92
-1.42%
6.4
Sell
Buy
Dolby Laboratories, Inc.

Events and news impacting Genpact Limited stock

Earnings, coporate decisions and industry developments that can affect the share price.

Genpact Limited fundamentals and technical analysis

Financial fundamentals and technicals signals combined to access stability, momentum and market direction.